Disialyloctasaccharide is primarily utilized in biomedical research and pharmaceutical development due to its role in cell signaling and immune system modulation. It is often studied for its potential in cancer therapy, as it can influence tumor growth and metastasis by interacting with specific cell surface receptors. Additionally, this compound is explored for its application in vaccine development, where it may enhance immune responses by mimicking natural glycans. Its ability to modulate inflammatory processes also makes it a candidate for treating autoimmune diseases and chronic inflammation. Researchers are further investigating its use in diagnostic tools to detect abnormal glycosylation patterns associated with various diseases.